Loading...
Promises and pitfalls for recombinant oligoclonal antibodies-based therapeutics in cancer and infectious disease
Monoclonal antibodies (mAbs) have revolutionized the diagnosis and treatment of many human diseases and the application of combinations of mAbs has demonstrated improved therapeutic activity in both preclinical and clinical testing. Combinations of antibodies have several advantages such as the capa...
Na minha lista:
| Udgivet i: | Curr Opin Immunol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier Ltd.
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7127534/ https://ncbi.nlm.nih.gov/pubmed/26995095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2016.03.001 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|